HBMSCs |
miR-26a-5p |
PTGS2 |
high |
could delay synovial fibroblast damage in vitro and reduce OA damage |
Jin et al. (2020b)
|
HBMSCs |
miR-320c |
N/A |
high |
promoting the proliferation of HBMSC chondrocytes and down-regulating matrix metallopeptidase 13 |
Sun et al. (2019)
|
MSCs |
miR-135b |
Sp1 |
high |
promote chondrocyte proliferation, thereby promoting cartilage repair |
Wang et al. (2018)
|
MSCs chondrocyte |
miR-92a-3p |
WNT5A |
high |
promoted cartilage proliferation and matrix gene expression in MSCs. |
Mao et al. (2018b)
|
Plasma |
miR-193b |
HDAC3 |
low |
promoting histone H3 acetylation and regulating the metabolism of primary human chondrocytes |
Lin et al. (2014)
|
human synovial mesenchymal stem cells |
miR-140-5p |
N/A |
high |
promote cartilage regeneration and delay the progression of knee OA |
Tao et al. (2017)
|
synovial fluid |
miR-200C |
N/A |
high |
miR-200C increased 2.5 times in OA exosomes compared to non-OA patients |
Rokavec et al. (2012)
|
primary chondrocytes |
miR-95-5p |
HDAC2/8 |
high |
regulated cartilage development and homogenous balance by directly targeting HDAC2/8 |
Mao et al. (2018a)
|
human exfoliated deciduous teeth |
miR-100-5p |
mTOR3’ untranslated region |
high |
inhibited the inflammation of temporomandibular joint (TMJ) chondrocytes |
Luo et al. (2019)
|
subchondral osteoblasts |
hsa-miR-4717-5p |
RGS2 |
high |
differentially expressed gene with the largest folding changes in the occurrence and progression of OA |
Liu et al. (2018a)
|
BMSCs |
miR-9-5p |
SDC1 |
N/A |
reduce inflammation and OA-like injury |
Jin et al. (2020a)
|
chondrocytes |
miR-8485 |
Wnt/β-catenin, GSK-3β |
N/A |
stimulating the cartilage differentiation of BMSCs |
Li et al. (2020)
|
IPFP-MSCs |
miR-100-5p |
mTOR |
high |
promote the abnormal gait of OA mice and reduce the pathological changes of articular cartilage in vivo
|
Wu et al. (2019)
|
chondrocytes |
lncRNA HULC |
N/A |
high |
promoted cell apoptosis and inhibits cell proliferation |
Song et al. (2017)
|
synovial fluid |
lncRNA PCGEM1 |
N/A |
high |
the exosomal lncRNA PCGEM1 may be a novel indicator to distinguish early OA from late OA |
Zhao and Xu, (2018)
|
MSCKLF3-AS1
|
lncRNA KLF3-AS1 |
miR-206/GIT1 axis |
high |
promoted the expression of GIT and alleviated the chondrocyte damage induced by IL-1β |
Liu et al. (2018b)
|
MSCs |
lncRNA KLF3-AS1 |
Col2a1 |
high |
inhibited IL-1β-induced chondrocyte apoptosis |
Liu et al. (2018c)
|
The Fibroblast-Like Synoviocyte |
lncRNA H19 |
miR-106b-5p/TIMP2 axis |
low |
inhibited the degradation of the matrix in OA |
Tan et al. (2020)
|
Human chondrocyte cell |
circ_0001846 |
miR-149–5p/WNT5B axis |
high |
modulated IL-1β-induced chondrocyte cell damage |
Zhu et al. (2021)
|
Human chondrocyte cell |
circ-BRWD1 |
miR-1277/TRAF6 axis |
high |
contributed to osteoarthritis development |
Guo et al. (2021)
|
MSCs |
circRNA_0001236 |
miR-3677-3p/Sox9 axis |
high |
enhanced chondrogenesis and suppress cartilage degradation |
Mao et al. (2021)
|